UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
April
02, 2026
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✔
Form 40-F
__
SMITH & NEPHEW PLC
2 April 2026
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
1. AWARDS MADE UNDER THE SMITH & NEPHEW PLC
DEFERRED SHARE BONUS PLAN
On 1 April 2026, the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Deferred Share Bonus Plan. The number
of Shares awarded has been calculated using a market price of
£12.744 per Share, being the average of the quoted closing
prices of a Share for the ten (10) dealing days immediately
following the announcement of the Company's full year 2025 results
on 2 March 2026.
A portion (50%) of the annual bonus earned by the following
Executive Directors for performance during the year to 31 December
2025 has been deferred into share awards. The awards will normally
vest on 15 March 2029. The Executive Directors will receive an
additional number of shares equivalent to the amount of dividend
payable per vested share during the relevant vesting
period.
|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Ordinary
Shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Awards granted on 1 April 2026 under the Deferred Share Bonus
Plan.
|
|
Date of Transaction
|
2026 - 04 - 01
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name
(Position)
|
Status
|
Price (s)
|
Volume(s)
|
Aggregated information
|
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
£12.744
|
83,494
|
N/A Single Transaction
|
|
John Rogers
(Chief Financial Officer)
|
Director
|
£12.744
|
48,071
|
N/A Single Transaction
|
2. PERFORMANCE SHARE AWARDS MADE UNDER THE SMITH &
NEPHEW PLC GLOBAL SHARE PLAN 2020
On 1 April 2026, the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Global Share Plan 2020. The number
of Shares awarded has been calculated using a market price of
£12.744 per Share, being the average of the quoted closing
prices of a Share for the ten (10) dealing days immediately
following the announcement of the Company's full year 2025 results
on 2 March 2026.
Awards will vest on 15 March 2029, subject to the achievement of
performance conditions which are measured over the period 1 January
2026 to 31 December 2028.
The number of shares subject to the above awards are shown at
maximum vesting. Should less than maximum vesting be achieved,
participants will receive a reduced number of shares in accordance
with actual performance. Participants will receive an additional
number of shares equivalent to the amount of dividend payable per
vested share during the relevant performance period.
|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Ordinary
Shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Awards granted on 1 April 2026 under the Global Share Plan
2020.
|
|
Date of Transaction
|
2026 - 04 - 01
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Deepak Nath
(Chief Executive Officer)
|
PDMR
|
£12.744
|
285,473
|
N/A Single Transaction
|
|
John Rogers
(Chief Financial Officer)
|
PDMR
|
£12.744
|
154,229
|
N/A Single Transaction
|
|
Helen Barraclough
(Group General Counsel & Company Secretary)
|
PDMR
|
£12.744
|
55,550
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
£12.744
|
51,531
|
N/A Single Transaction
|
|
Ajay Dhankhar
(Chief Strategy & Corporate Development Officer)
|
PDMR
|
£12.744
|
110,751
|
N/A Single Transaction
|
|
Craig Gaffin
(President Orthopaedics)
|
PDMR
|
£12.744
|
91,258
|
N/A Single Transaction
|
|
Rohit Kashyap
(President AWM & Global Commercial Operations)
|
PDMR
|
£12.744
|
112,073
|
N/A Single Transaction
|
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
£12.744
|
53,921
|
N/A Single Transaction
|
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
£12.744
|
67,747
|
N/A Single Transaction
|
|
Vasant Padmanabhan
(President Research & Development, ENT & Emerging
Markets)
|
PDMR
|
£12.744
|
71,044
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
£12.744
|
19,679
|
N/A Single Transaction
|
|
Scott Schaffner
(Global President Sports Medicine)
|
PDMR
|
£12.744
|
107,053
|
N/A Single Transaction
|
3. AWARDS MADE UNDER THE SMITH & NEPHEW PLC
RESTRICTED SHARE PLAN 2024
On 1 April 2026, the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Restricted Share Plan 2024.
The number
of Shares awarded has been calculated using a market price of
£12.744 per Share, being the average of the quoted closing
prices of a Share for the ten (10) dealing days immediately
following the announcement of the Company's full year 2025 results
on 2 March 2026.
The awards will normally vest in equal annual tranches over three
years following the award date. In addition, Deepak Nath's and John
Rogers' awards are subject to a reasonable judgement underpin. If
the Remuneration Committee is not satisfied that the underpin has
been met, the Committee may scale back the vesting (including to
zero). In assessing the underpin, the Committee will consider a
review of overall financial performance over the vesting period,
whether there have been any sanctions or fines issued by a
regulatory authority, whether there have been any material
environmental, social or governance issues, whether a major safety
incident has occurred and whether there has been material damage to
the reputation of the Company.
Participants will receive an additional number of shares equivalent
to the amount of dividend payable per vested share during the
relevant vesting period.
|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Ordinary
Shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Awards granted on 1 April 2026 under the Restricted Share Plan
2024.
|
|
Date of Transaction
|
2026 - 04 - 01
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Deepak Nath
(Chief Executive Officer)
|
PDMR
|
£12.744
|
118,947
|
N/A Single Transaction
|
|
John Rogers
(Chief Financial Officer)
|
PDMR
|
£12.744
|
64,262
|
N/A Single Transaction
|
|
Helen Barraclough
(Group General Counsel & Company Secretary)
|
PDMR
|
£12.744
|
21,927
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
£12.744
|
26,443
|
N/A Single Transaction
|
|
Ajay Dhankhar
(Chief Strategy & Corporate Development Officer)
|
PDMR
|
£12.744
|
42,009
|
N/A Single Transaction
|
|
Craig Gaffin
(President Orthopaedics)
|
PDMR
|
£12.744
|
24,230
|
N/A Single Transaction
|
|
Rohit Kashyap
(President AWM & Global Commercial Operations)
|
PDMR
|
£12.744
|
55,263
|
N/A Single Transaction
|
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
£12.744
|
21,284
|
N/A Single Transaction
|
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
£12.744
|
34,764
|
N/A Single Transaction
|
|
Vasant Padmanabhan
(President Research & Development, ENT & Emerging
Markets)
|
PDMR
|
£12.744
|
28,043
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
£12.744
|
7,379
|
N/A Single Transaction
|
|
Scott Schaffner
(President Sports Medicine)
|
PDMR
|
£12.744
|
64,970
|
N/A Single Transaction
|
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
April 02, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|